Hangzhou TianMuShan Pharmaceutical EnterpriseLtd Balance Sheet Health
Financial Health criteria checks 1/6
Hangzhou TianMuShan Pharmaceutical EnterpriseLtd has a total shareholder equity of CN¥56.5M and total debt of CN¥87.5M, which brings its debt-to-equity ratio to 154.8%. Its total assets and total liabilities are CN¥366.4M and CN¥309.8M respectively.
Key information
154.8%
Debt to equity ratio
CN¥87.45m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥30.43m |
| Equity | CN¥56.51m |
| Total liabilities | CN¥309.84m |
| Total assets | CN¥366.35m |
Financial Position Analysis
Short Term Liabilities: 600671's short term assets (CN¥150.3M) do not cover its short term liabilities (CN¥230.3M).
Long Term Liabilities: 600671's short term assets (CN¥150.3M) exceed its long term liabilities (CN¥79.5M).
Debt to Equity History and Analysis
Debt Level: 600671's net debt to equity ratio (100.9%) is considered high.
Reducing Debt: 600671's debt to equity ratio has increased from 92.1% to 154.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 600671 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 600671 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 45.9% each year